Walleye Capital’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100,921
Closed -$407K 4525
2025
Q2
$407K Buy
100,921
+87,814
+670% +$286K ﹤0.01% 2806
2025
Q1
$35.8K Buy
+13,107
New +$47K ﹤0.01% 3924
2020
Q4
Sell
-100,104
Closed -$1.01M 946
2020
Q3
$1.01M Sell
100,104
-9,663
-9% -$97.6K 0.11% 237
2020
Q2
$1.09M Buy
109,767
+2,126
+2% +$20.9K 0.24% 123
2020
Q1
$1.04M Buy
+107,641
New +$1.07M 0.23% 125

Other funds holding SRTA

Walleye Capital's SRTA Position: Q3 2025 in Review

Walleye Capital sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 100,921 shares — an estimated $407K sold.

Walleye Capital first reported a position in SRTA in Q1 2020 and held it in 5 quarters. The position peaked at $1.09M in Q2 2020. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • Walleye Capital reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • Walleye Capital sold 100,921 Strata Critical Medical Inc shares in Q3 2025, an estimated $407K.
  • Walleye Capital first reported a position in Strata Critical Medical Inc in Q1 2020 and held it in 5 quarters.
  • Walleye Capital's Strata Critical Medical Inc position peaked at $1.09M in Q2 2020.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.